GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4922)

  • GC70868 structure
    GC70868Nrf2 activator-3
    CAS: 2766570-23-2
    Purity: >98.00%

    Nrf2 activator-3 هو منشط Nrf2 قوي.

  • GC70953 structure
    GC70953α7 nAchR-JAK2-STAT3 agonist 1
    CAS: 2108714-20-9

    α7 nAchR-JAK2-STAT3 agonist 1 هو ناهض قوي α7 nAchR-JAK2-STAT3، بقيمة IC50 0.32 ميكرومتر لأكسيد النتريك (NO).

  • GC70971 structure
    GC70971S-HP210
    Purity: >98.00%

    S-HP210 هو مستقبلات القشرانيات السكرية الفعالة والانتقائية (GR) مع قيمة IC50 من 1.92 ميكرومتر ل NF-κB transالقمع (TR).

  • GC70972 structure
    GC70972R-HP210
    Purity: >98.00%

    يعمل R-HP210 على وظيفة القمع المربوط بوساطة NF-κB (IC50=3.80 ميكرومتر).

  • GC70979 structure
    GC70979Anti-inflammatory agent 38
    CAS: 3032633-42-1
    Purity: >98.00%

    Anti-inflammatory agent 38 (المركب 23d) هو مثبط مسار نrf2/HO-1، مع قيمة IC50 من 0.38 μM ل NO.

  • GC70987 structure
    GC70987Avacincaptad pegol sodium
    CAS: 1491144-00-3
    Purity: >98.50%

    Avacincaptad pegol sodium هو أبتامر الحمض النووي الريبي المضاد لـ C5 الذي يمنع انقسام العامل المتمم 5 (C5) إلى C5a و C5b.

  • GC71003 structure
    GC71003ALPK1-IN-1
    CAS: 2765457-72-3
    Purity: >99.00%

    ALPK1-IN-1 (المركب A001) هو مثبط قوي لألفا كيناز 1 (ALPK1).

  • GC71031 structure
    GC71031Nrf2 activator-6
    CAS: 2728780-74-1

    Nrf2 activator-6، مركب تيتراهيدروإيزوكينولين، هو منشط Nrf2.

  • GC71072 structure
    GC71072NXPZ-2
    CAS: 2254492-08-3
    Purity: >98.00%

    NXPZ-2 هو مثبط تفاعل البروتين -البروتين Keap1-Nrf2 النشط عن طريق الفم (PPI) مع قيمة Ki من 95 نانومتر، قيمة EC50 من 120 و 170 نانومتر.

  • GC71113 structure
    GC71113IL-2-IN-1
    CAS: 245747-10-8
    Purity: >99.00%

    IL-2-IN-1 هو مثبط قوي IL-2 مع قيمة IC50 1978 نانومتر.

  • GC71119 structure
    GC71119UBX1325
    CAS: 2271269-01-1
    Purity: >98.00%

    UBX1325 هو مثبط Bcl-xL الذي يعزز موت الخلايا المبرمج في الخلايا الحساسة.

  • GC71123 structure
    GC71123Galectin-8N-IN-1
    CAS: 2667628-25-1
    Purity: >98.00%

    Galectin-8N-IN-1 (مركب 19a) هو مثبط فعال وانتقائي للجالكتين -8N بقيمة Kd 1.8 ميكرومتر.

  • GC71128 structure
    GC71128Diclofenac-d4 sodium
    CAS: 154523-54-3
    Purity: >99.00%

    Diclofenac-d4 sodium هو الديوتيريوم المسمى صوديوم ديكلوفيناك.

  • GC71144 structure
    GC71144Phytoene desaturase-IN-1
    CAS: 2765793-54-0
    Purity: >99.00%

    يعتبر Phytoene desaturase-IN-1 مثبط إنزيم desaturase فايتوين قوي (PDS) (Kd:65.9 ميكرومتر) من خلال تأثير التكديس π−π مع بقايا Phe301.

  • GC71149 structure
    GC71149NIC-0102
    CAS: 2806031-94-5
    Purity: >98.00%

    NIC-0102 هو مثبط بروتيزوم نشط عن طريق الفم (pIC50=7.55) الذي يمنع على وجه التحديد تنشيط الحويصلة الالتهابية NLRP3.

  • GC71181 structure
    GC71181Glucocorticoid receptor modulator 1
    CAS: 2868357-11-1
    Purity: >99.00%

    Glucocorticoid receptor modulator 1 is a highly potent and orally active non-steroidal selective glucocorticoid receptor modulator with an IC50 value of 9 nM and 130 nM for NF-κB and AP-1, respectively.

  • GC71186 structure
    GC71186STING-IN-4
    CAS: 2250374-27-5
    Purity: >99.00%

    STING-IN-4 (المركب 1) هو مثبط STING الذي يمنع التعبير عن STING وبالتالي يقلل من تنشيط STING وإشارة العامل النووي κB (NF-κB).

  • GC71189 structure
    GC71189STING-IN-5
    CAS: 2920064-17-9

    STING-IN-5 هو مثبط قوي STING، يثبط أي توليف ناتج عن LPS-NO في البلاعم مع قيمة IC50 من 1.15 ميكرومتر.

  • GC71230 structure
    GC71230NLRP3-IN-17
    CAS: 2254432-75-0
    Purity: >99.00%

    يعتبر NLRP3-IN-17 مثبط التهاب NLRP3 فعال وانتقائي وفموي مع قيمة IC50 من 7 نانومتر.

  • GC71232 structure
    GC71232I-152
    CAS: 311343-11-0
    Purity: >98.00%

    I-152 هو مركب يحتوي على N-acetyl-cysteine (NAC) و cysteamine (MEA).

  • GC71258 structure
    GC71258ASK1-IN-4
    CAS: 1427538-26-8

    ASK1-IN-4 (المركب 17) هو مثبط ASK1 (IC50=0.2 ميكرومتر).

  • GC71259 structure
    GC71259NH2-C6-ARC186 sodium
    Purity: >92.00%

    NH2-C6-ARC186 sodium هو تعديل ARC186 مع NH2-C6 التي يمكن أن تقترن مع الببتيدات أو الجزيئات الأخرى.

  • GC71273 structure
    GC71273C12-TLRa
    Purity: >99.00%

    C12-TLRa هو lipidoid مساعد.

  • GC71351 structure
    GC71351HMGB1-IN-1
    Purity: >95.00%

    HMGB1-IN-1 (المركب 6) يظهر تأثير مثبط قوي في خلايا RAW264.7 بقيمة IC50 15.9 ± 0.6 ميكرومتر.